MedPath

Barriers to Referring Adolescent Women for Etonogestrel Implant.

Not Applicable
Withdrawn
Conditions
Contraceptive Usage
Interventions
Behavioral: Education plus Coaching
Registration Number
NCT04882137
Lead Sponsor
Nemours Children's Clinic
Brief Summary

This study seeks to understand how much pediatric providers in Central Florida know about the etonogestrel contraceptive implant. The investigators also seek to understand the barriers that may prevent them from referring adolescent women for this highly effective and recommended method of contraception. Finally the study will consider if an expanded education and coaching improves their ability to referring patients for this method of birth control.

Detailed Description

This study is comprised of two phases. During the first phase 500 medical providers who provide care to adolescents will be recruited to complete a 30 question anonymous survey that evaluates their attitudes towards recommending and referring for adolescent women for the etonogestrel contraceptive device. This survey will also test participant's knowledge of indications, side effects and side effect management related to this contraceptive device as well.

During phase 2, 100 pediatric providers will be randomized to two groups. One group will receive standard continuing medical education on the use of the etonogestrel device in adolescents focusing on themes that emerged as knowledge deficits in phase 1. The other group will receive standard continuing medical education plus continued coaching on management of medication side effects. The referring patterns of physicians in each group will be studied.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • A primary care provider that cares for children under the age of 18. This includes physician's assistants, advanced nurse practitioners, residents or fellows, and physicians in pediatrics, internal medicine, and family medicine.
  • Must currently be practicing in Central Florida.
  • Be able to speak and write in English
  • For phase two of the study an additional requirement is that you must have a medical license to practice independently in the state of Florida.
Read More
Exclusion Criteria
  • Not a primary care provider who cares for children.
  • A pediatric provider who only provides specialty care
  • Not able to speak or write in English
  • For phase two of study does not have a medical license to practice independenly in the State of Florida.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Education plus CoachingEducation plus CoachingPediatric Providers in this arm will receive a continuing medical education program on etonogestrel contraceptive implant. Providers in this arm will also receive a tip-sheet on how to manage side effects as well as a number to directly access a specialist who places them if needed.
Primary Outcome Measures
NameTimeMethod
Types of barriers to referral for etonogestrel implant based on questionnaire6 months

Barriers to recommending and referring adolescent women for etonogestrel contraceptive implant

Number of adolescent women referred18 months

Number of adolescent women who were referred for etonogestrel contraceptive implant

Secondary Outcome Measures
NameTimeMethod
Categories of knowledge deficit in pediatric providers based on questionaire6 months

Understanding whether pediatric providers main knowledge deficit around etonogestrel implant is indications, side effects, or decreasing side effects.

Aspects in Coaching that changed pediatric providers' behaviors18 months

Qualitative analysis on which parts of coaching or standard intervention were most considered in referring.

© Copyright 2025. All Rights Reserved by MedPath